BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1935 related articles for article (PubMed ID: 28161329)

  • 1. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities.
    Baffy G
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):655-664. PubMed ID: 28088333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.
    Srinivasan S; Guha M; Kashina A; Avadhani NG
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):602-614. PubMed ID: 28104365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial metabolism and energy sensing in tumor progression.
    Iommarini L; Ghelli A; Gasparre G; Porcelli AM
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):582-590. PubMed ID: 28213331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy metabolism in skin cancers: A therapeutic perspective.
    Hosseini M; Kasraian Z; Rezvani HR
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):712-722. PubMed ID: 28161328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic synthetic lethality in cancer therapy.
    Zecchini V; Frezza C
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):723-731. PubMed ID: 27956047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of mitophagy in carcinogenesis and tumor progression.
    Chang JY; Yi HS; Kim HW; Shong M
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):633-640. PubMed ID: 28017650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer metabolism in space and time: Beyond the Warburg effect.
    Danhier P; BaƄski P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers.
    De Luise M; Girolimetti G; Okere B; Porcelli AM; Kurelac I; Gasparre G
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):591-601. PubMed ID: 28115060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and putative role of mitochondrial transport proteins in cancer.
    Lytovchenko O; Kunji ERS
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):641-654. PubMed ID: 28342810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDAC in cancer.
    Mazure NM
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):665-673. PubMed ID: 28283400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
    Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in cancer chemoresistance.
    Guaragnella N; Giannattasio S; Moro L
    Biochem Pharmacol; 2014 Nov; 92(1):62-72. PubMed ID: 25107705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis.
    Ekoue DN; He C; Diamond AM; Bonini MG
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):628-632. PubMed ID: 28087256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial determinants of cancer health disparities.
    Choudhury AR; Singh KK
    Semin Cancer Biol; 2017 Dec; 47():125-146. PubMed ID: 28487205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.